Literature DB >> 18681081

Impact of specific allergen sensitization on the prevalence of asthma in patients with allergic rhinitis from adjacent distinct geographic areas.

Yuri Zeldin1, Mona I Kidon, Eli Magen, Haim Bibi, Amnon Cohen, Yoav Waisel, Shmuel Kivity.   

Abstract

BACKGROUND: Patients with allergic rhinitis (AR) and perennial allergen sensitization are at increased risk for asthma.
OBJECTIVES: To determine the allergic profile of patients with clinical AR in regions of the coastal Mediterranean compared with the inland southern desert area of Israel and the impact of specific allergen sensitization on the prevalence of asthma in these patients.
METHODS: Retrospective evaluation of medical records from patients referred for evaluation during 2002 and 2003 to the allergy clinics of 3 medical centers located in different geoclimatic areas.
RESULTS: A total of 479 patients with AR were included (64% from the humid Mediterranean coast and 36% from the arid desert area), with a mean age of 32.8 years (range, 6-84 years). Sixty percent of the patients were male, and 33% had an additional diagnosis of asthma. Mite sensitization was 84%; cockroach, 34%; trees, 43%; weeds, 40%; grasses, 53%; and fungi, 30%. There were no significant differences in the prevalence of sensitization to any of the evaluated allergens except for weeds, which was higher in the arid region. A diagnosis of asthma was significantly associated with mite sensitization in the Mediterranean area (odds ratio, 2.24; 95% confidence interval, 1.14-4.4; P = .02) and mold sensitization in the arid climate zone (odds ratio, 2.18; 95% confidence interval, 1.05-4.6; P = .04).
CONCLUSION: Although sensitization to mites is high in the coastal areas and in the Negev desert-like environment, the presence of asthma in patients with AR is associated with mite sensitization in the humid environment but with fungal sensitization in the more arid environment.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18681081     DOI: 10.1016/S1081-1206(10)60831-9

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN: 1081-1206            Impact factor:   6.347


  7 in total

1.  Sensitization pattern of inhalant allergens in children with asthma who are living different altitudes in Turkey.

Authors:  Emin Ozkaya; Ayhan Sogut; Mehmet Küçükkoç; Mustafa Eres; Hamit Acemoglu; Hasan Yuksel; Naci Murat
Journal:  Int J Biometeorol       Date:  2015-03-04       Impact factor: 3.787

2.  Th2 allergic immune response to inhaled fungal antigens is modulated by TLR-4-independent bacterial products.

Authors:  Jenna B Allard; Lisa Rinaldi; Matthew J Wargo; Gilman Allen; Shizuo Akira; Satoshi Uematsu; Matthew E Poynter; Deborah A Hogan; Mercedes Rincon; Laurie A Whittaker
Journal:  Eur J Immunol       Date:  2009-03       Impact factor: 5.532

3.  House dust allergy and immunotherapy.

Authors:  Wayne R Thomas
Journal:  Hum Vaccin Immunother       Date:  2012-08-16       Impact factor: 3.452

4.  Association of molds and metrological parameters to frequency of severe asthma exacerbation.

Authors:  Mona Al-Ahmad; Edin Jusufovic; Nermina Arifhodzic; Tito Rodriguez; Jasmina Nurkic
Journal:  Allergy Asthma Clin Immunol       Date:  2019-04-29       Impact factor: 3.406

5.  Conditions associated with childhood asthma in north Texas.

Authors:  Patricia Newcomb; Alaina Cyr
Journal:  ISRN Allergy       Date:  2012-09-24

6.  Prevalence and triggers of allergic rhinitis in the United Arab Emirates.

Authors:  Bassam Mahboub; Suleiman Al-Hammadi; Vijayshree P Prakash; Nabil Sulaiman; Michael S Blaiss; Abdulla Al Redha; Deepa M Vats
Journal:  World Allergy Organ J       Date:  2014-08-01       Impact factor: 4.084

7.  A cross-sectional observational study on allergen-specific IgE positivity in a southeast coastal versus a southwest inland region of China.

Authors:  Guangqiao Zeng; Wenting Luo; Zehong Wu; Ling Li; Peiyan Zheng; Huimin Huang; Nili Wei; Jiaying Luo; Baoqing Sun; Yong Liu
Journal:  Sci Rep       Date:  2017-08-30       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.